Optimal timing for pegfilgrastim administration in Japanese breast cancer patients receiving intermediate-risk chemotherapies: response to study by Hayama et al.
Henry, David H., Weycker, Derek, Bensink, Mark, Gawade, Prasad, Belani, RajeshLanguage:
english
Journal:
International Journal of Clinical Pharmacy
DOI:
10.1007/s11096-018-0752-3
Date:
April, 2019
File:
PDF, 305 KB
english, 2019